H Sultan, M AlNasser, A Assiri, F Tawhari, A Bakkari, M Mustafa, W Alotaibi, A Asiri, A Khudari, A Alshreem, M Ayoub, S Alkhathami, H Basndwah, O Alsaeed, M Alkredees, T Alsalem, A Alhuwail, T Almalki, Y Alzahrani, F Alshahrani, B Alqahtani, B Alghamdi, A R N Ibrahim, M Zaitoun
OBJECTIVE: This study aimed to assess the appropriateness of direct oral anticoagulants (DOACs) utilization in a Saudi tertiary hospital. PATIENTS AND METHODS: Adult inpatients and outpatients diagnosed with atrial fibrillation, deep vein thrombosis, or pulmonary embolism were included in a retrospective cohort study. Patients received at least one month of apixaban, rivaroxaban, or dabigatran. The duration of the study at the Armed Forces Hospital Southern Region in Khamis Mushait, Saudi Arabia, was from January 1, 2019, to December 31, 2021...
October 2023: European Review for Medical and Pharmacological Sciences